Utilization and Dose Optimization of Angiotensin‐Converting Enzyme Inhibitors in Heart Failure Patients With Reduced Ejection Fraction: A Cross Sectional Study on Implications for Guideline‐Targeted Therapy

Documenti analoghi

• Awareness and willingness to use pre‐exposure prophylaxis among the University of Zambia students: A cross‐sectional study
  di: Martin Kampamba, et al.
  Pubblicazione: (2024)
• Letter to the Editor: “Reducing the Risk of Developing Diabetes: The Role of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors in Patients With Hypertension Combined Prediabetes”
  di: Sabika Ayesha, et al.
  Pubblicazione: (2025)
• A Letter to the Editor on “Reducing the Risk of Developing Diabetes: The Role of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors in Patients with Hypertension Combined Prediabetes”
  di: Ghaniya Khan
  Pubblicazione: (2025)
• Outcomes of Left Atrial Appendage Occlusion in Heart Failure With Reduced Ejection Fraction
  di: Aamer Ubaid, et al.
  Pubblicazione: (2026)
• Angiotensin Receptor–Neprilysin Inhibitor in Heart Failure Patients With Renal Dysfunction
  di: Xiaogang Zhu, et al.
  Pubblicazione: (2024)